Melek, H. Et Al. 2012. Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival. Chicago Multidisciplinary Symposium in Thoracic Oncology , (Illinois, United States Of America), 165.

Melek, H., Erol, M., Bayram, A. S., Evrensel, T., Sarıhan, S., Akyıldız, E. Ü., ... Gebitekin, C.(2012). Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival . Chicago Multidisciplinary Symposium in Thoracic Oncology (pp.165). Illinois, United States Of America

Melek, HÜSEYİN Et Al. "Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival," Chicago Multidisciplinary Symposium in Thoracic Oncology, Illinois, United States Of America, 2012

Melek, HÜSEYİN Et Al. "Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival." Chicago Multidisciplinary Symposium in Thoracic Oncology , Illinois, United States Of America, pp.165, 2012

Melek, H. Et Al. (2012) . "Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival." Chicago Multidisciplinary Symposium in Thoracic Oncology , Illinois, United States Of America, p.165.

@conferencepaper{conferencepaper, author={HÜSEYİN MELEK Et Al. }, title={Neoadjuvant treatment followed by surgery in patients with N2 NSCLC: is complete response a better sign of long term survival}, congress name={Chicago Multidisciplinary Symposium in Thoracic Oncology}, city={Illinois}, country={United States Of America}, year={2012}, pages={165} }